About AbbVie

AbbVie is a global biopharmaceutical company that develops and markets a range of pharmaceutical products, including immunology, oncology, and virology treatments, such as Humira, Skyrizi, and Venclexta. The company's portfolio also includes AndroGel, a testosterone replacement therapy, and Imbruvica, a treatment for certain types of blood cancer. As a leading player in the pharmaceutical industry, AbbVie plays a significant role in addressing various health needs and improving patient outcomes.